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Coronary stents are slotted tubes made of metals, alloys, or polymers. They are deployed in 
human arteries, which are blocked by calcified plaque, to keep the arteries open and allow the 
blood to flow with ease. Coronary stents have been proven as an effective treatment device for 
heart diseases such as acute myocardial infarction.  
Design plays an important role for coronary stents to perform the clinical functions properly. 
Various parameters such as materials, structures, dimensions, and deployment methods etc., need 
to be considered in the design of coronary stents. There are numerous studies on design of 
coronary stents and many significant manufacturing methods have been reported in the past two 
decades. However, there is no comprehensive methodology for the product development of 
coronary stents in terms of design, simulation, and manufacturing. 
The objective of this research is to develop a methodology for coronary stents product 
development that focuses on design, simulation, and manufacturing. The methodology brings 
together insights from numerous engineering design disciplines with the aim of making coronary 
stent development more flexible and more cost-efficient 
The product development methodology for coronary stents is executed through modeling and 
analyzing stent designs with details of design, simulation, and optimization methods. Three 
innovative stent designs are modeled using engineering design software (SolidWorks) and 
mechanical performances are simulated, evaluated, and optimized with the help of advanced 
engineering simulation software (ANSYS). In this study, the performance of stents based on 
stress, strain, and total deformation during deployment are analyzed and compared with 











1.1 Coronary Stents 
Nowadays, interventional cardiology is one of the medical treatments highly performed 
by cardiologists. It is a minimally invasive treatment to allow proper functioning of the heart, 
arteries and veins. Atherosclerosis is a heart disease treated by interventional cardiology. In 
atherosclerosis, a plaque which is a composition of fat, cholesterol, fibrin, and calcium develops 






Figure 1. Cross sectional view of coronary artery with lesion. 
The plaque forms a blockage and impedes the flow of blood which leads to myocardial 
infarction i.e., heart attack (Chua, 2004 a). In medicine, the blockage is treated by expanding a 
balloon or inserting a stent or combination of both procedures at the clogged site. Based upon the 
medical devices such as the balloon and stent used on the catheter, the treatments are further 
specified as balloon angioplasty and stent deployment procedures (Trozera, 2003). Both of these 
procedures are practiced to expand the passage in the arteries and veins for the blood to flow 
with ease. 
The stent deployment procedure is implemented in the following steps as demonstrated 
















Figure 2. Catheter loaded with balloon stent. 
                   
Figure 3. Stent deployed inside the blocked artery. 
1) A guide wire is passed through the afflicted site. 
2) A balloon with crimped stent loaded on catheter is inserted through a guide wire and 
passed to the site (Lally, 2006). 
3) The balloon is expanded with 20 atm (Maguire, 2005) pressure to expand and deploy the 
stent at the blockage area to make the passage open.  
4) The expanded stent remains at the blockage inside the artery, while the catheter with 
balloon and guide wire is removed (Lim, 2004). 
Stents are one of the medical devices widely used to treat cardiovascular diseases. It is 
reported that these medical devices command a huge market which accounts for $30 billion as of 













million people are treated with coronary stents (Anonymous (a), 2010) in the world. According 
to a medicine market report, coronary stents accounted for about $7.1 billion in 2011 and will 
increase to $10.6 billion by 2016 (Anonymous (b), 2012). 
1.2 Technical Trends and Challenges 
Coronary stents were first introduced in 1986, since then researchers have developed 
many different stents with various materials, designs and manufacturing methods (Liang, 2005). 
Technically speaking, they can be classified into different types according to medical 
applications, deployment methods, materials, forms, patterns, coatings, manufacturing methods, 
and other aspects. For instance, coronary stents can be classified as Balloon Expandable Stents 
(BES) and Self Expandable Stents (SES) according to deployment methods and materials. BES’s 
are deployed using a balloon as shown in Figure 2. The materials used for BES’s are tantalum, 
stainless steel, platinum, cobalt-chromium, etc., (Stockel, 2002). SES’s expand themselves inside 
the artery at a temperature of 37
0
C (Venkatraman et al., 2006). Nitinol is considered as a self-
expandable stent material which is made of nickel and titanium. There are many classifications 
of stents within the past 25 years and they are summarized in Figure 4. 
The efficacy, long term safety, and clinical outcomes are important aspects considered in 
medical studies (Cutlip, 2007). Despite research proposed various types of stents with respect to 
design and manufacturing, many clinical studies report stent thrombosis, restenosis, hyperplasia, 
and myocardial infarction in patients. Numerous studies are continued on bare metal versus drug 
eluting stents, as bare metal stents show high restenosis rates while drug eluting stents show high 
thrombosis rates (Luscher, 2007). In addition to these stent varieties, researchers have proposed 


























Figure 4. Stents classification (source: Stockel, 2002 and Lally, 2006). 
Many stent designs with the above mentioned materials have been introduced in the 
market to prove their preeminence against each other. The designs vary with strut shapes, sizes 
and diameters. Nowadays, stents have very small diameters which range from 2.5 mm- 5.5 mm 
(Butany et al., 2005) with thin struts. Thick strut stents have been used for decades. Stents with 
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Hence, thin strut stents are introduced in the market. High contact area between stent and plaque 
(i.e., metal to artery ratio) cause thrombosis and restenosis (Lau, 2004b); therefore, thin strut 
stents have been proven better performances because of less vascular injury (Lau et al., 2004b) 
and low metal to artery ratio.     
Apart from the design aspects, manufacturing methods also play vital role as they face 
stent efficacy challenges. Stent surface characteristics such as burrs, oxide layer formations 
caused during manufacturing lead to thrombosis and hyperplasia (Mani, 2007 & Zhao, 2003). 
Therefore, precision manufacturing techniques such as laser machining, photochemical etching, 
electro-discharge machining, water jet, braiding, vapor deposition, etc., are considered necessary 
to manufacture the stents (Stockel, 2002) and to overcome such drawbacks. Proper surface 
treatment techniques must be carried out to remove burrs and oxidation layers. 
1.3 Research Scope 
The interaction between stent, balloon, and artery play a significant role during 
deployment. Deployment of the stents in the arteries leads to pressure exertion on the artery 
walls. High pressure exertion at the plaque site precedes vascular injury. So, design of the stent 
struts plays a major role in successful deployment and functioning of stent.  
Simulation of stent, balloon, artery, and plaque helps to imitate the stress study on the 
stent and arterial wall. Computer aided design and finite element analysis software provide 
inexpensive simulation results for stent behavior. Recently, simulation studies have concentrated 
on the deployment behavior of stent, balloon and their effects on plaque and artery. The aspects 
of stent behavior that are studied in research involve elastic recoil, foreshortening, longitudinal 
recoil, dogboning, radial stiffness, coverage area, fracture mechanics, bending and flexibility 








Materials of the stents also have a great effect on the stent performance. The materials are 
selected on the basis of mechanical properties, biocompatibility and biofunctionality (Lally et al, 
2006). Significantly, every material has its own importance as per the biocompatibility and 
flexibility parameters are concerned. The material selection varies from metals, composites, 
polymers, and ceramics. Sometimes, stents are made from combination of materials such as 
stainless steel and nitinol for flexibility, gold or platinum for rigidity and radiopaqueness 
(Kuehling, 2010). Another important material aspect considered in current studies is the 
biodegradability of stents. Stents are expected to stay in the body for a period of 12-24 months 
and biodegrades after the artery is back to its normal position (Hermawan, 2010). The proper 
biodegradable material also prevents early recoiling of stents (Kandzari, 2002). Hence, the 
research on biodegradable materials is on pace. 
The method of manufacturing matters in proper functioning of stents. Surface finishing is 
a machining operation which is an important process after manufacturing stents. Burrs, 
roughness and oxide layer formation on the material affects the proper functioning of stent and 
surface finishing treatments are in use to eliminate them (Koós, 2007 & Mani, 2007).  
Material, design, manufacturing, clinical outcomes are some characteristics, the 
researchers investigate in the field of coronary stents. Thus, this study provides a new product 
development methodology for coronary stents with emphasis on design, simulation and 
manufacturing. 
1.4 Product Development Strategy 
Product developments are phases of the product from concept to product life in the 
market. In detail, the phases include idea generation, feasibility study, product design, simulation 








market. This research concentrates on the product development methodology of coronary stents 
and elaborates the conceptual phase, design phase and manufacturing methods.  The 
methodology is implemented by modeling and testing novel stent designs from the objectives of 
conceptual and design phases. 
1.5 Research Motivation 
Plaque formation differs from one artery to another (Kandzari, 2002), so, many kinds of 
stents are introduced in the market to deploy in the complex passages. Drug carrying stents are 
required to prevent restenosis, hyperplasia and thrombosis. In 2002, there were 43 coronary 
stents and stent families available in the market (Gay, 2006). Even though there are many stent 
designs available, the clinicians and medical device manufacturers are looking for new stent 
designs to deploy in complex plaque strictures and to achieve exceptional clinical outcomes. 
Hence, there is great requirement for new stent designs in the current health care environment. 
Computer aided design and finite element analysis software which provides design and 
simulation results, helps to study many engineering aspects and act as better cost and time 
effective solutions. The designs can be further remodeled according to the simulation results and 
obtain effective outcomes. Magnesium is a biodegradable material and has low thrombosis rates 
(Erne et al., 2006). Therefore, the stent designs in this research are studied by design and 
simulation software by comparing the designs with magnesium alloys and other biocompatible 
materials.  
1.6 Outline 
Chapter 1 introduces deployment procedure of stents, classification of stents, product 








Chapter 2 reviews the literature on stent materials, design requirements and 
manufacturing methods that were developed in the past years.  
Chapter 3 explains the product development of coronary stents from concept stage, 
design, simulation, manufacturing to clinical outcomes. This chapter proposes product 
development methodology of coronary stents with emphasis on design, simulation and 
manufacturing. 
The product development methodology introduced in chapter 3 supports to design three 
novel stents. Chapter 4 discusses the geometry and dimensions of the novel stents. 
Chapter 5 demonstrates the simulation of the novel stents with biomaterials such as 
stainless steel, cobalt-chromium and magnesium. In addition, the novel stents are simulated with 
various magnesium alloys and compared the outcome with one of the stents available on the 
market. The chapter interprets simulation results and the performances of the stents. 
Chapter 6 reviews the significance of this research work and further recommends future 


















Stents are medical devices inserted in the human body through minimal invasive 
treatments. Minimal invasive treatments have increased since 1980 because of the small 
incisions and less recovery time (Song, 2010). Stents are inserted at the afflicted site to ease the 
flow of fluids and to prevent blockages. Stents are deployed in various parts of the human body 
such as brain, cerebral arteries and veins, neck, trachea, esophagus, bronchial tubes, coronary, 
peripheral, biliary ducts, iliac arteries, renal, and urethras (Kuehling, 2010; Shedlov, 2005 & 
Weber, 2003).   
 Coronary stents are implanted in cardiovascular treatments to prevent myocardial 
infarctions. These are deployed in complex plaque strictures of coronary arteries. The 
performances of stents are studied after deployment which incorporates the factors that affect 
vascular compatibility, mechanical support offered, and design effectiveness (Pant et al., 2011). 
These are the factors that lead to restenosis, thrombosis, and neointimal formation (Pant et al., 
2011). Thus; material, design, and manufacturing method play an important role in proper 
functioning of the stent (Stockel et al, 2002). This chapter reviews materials in section 2.1; 
clinical performance in section 2.2; design requirements in section 2.3; shape, size, and structure 
in section 2.4; and manufacturing methods of stents in section 2.5.  
2.1 Material Selection 
Cardiovascular stent material engages in an important role in the clinical performance 
because of the mechanical support offered to the artery and compatibility of the material to the 
artery (Zhao, 2003). The materials of stents are selected on the basis of mechanical properties, 








thromboresistant), and biological inertness (Lally, 2006). These materials are classified into 
metals, metal alloys, polymers, and ceramics. These classifications are described with materials 






Figure 5. Properties of ceramics, metals, and polymers (adapted from Fischer, 2008). 
Metals play significant roles in stent materials, because of their optimal mechanical 
characteristics offered to recover the artery (Zhao, 2003). They have a high elastic modulus due 
to high tensile strength, leading to low stresses in the material (Kranz, 1999). Thus, metals such 
as iron, titanium, tantalum, cobalt, chromium, magnesium, nickel, iron, zinc, etc.; are 
biocompatible and are considered as biomaterials (Kuehling, 2010).  
Metal alloys are mixtures of two or more materials in certain amounts to obtain better 
performance properties. The amount of strength, ductility, and toughness of the material; matters 
during the selection of the material (Kuehling, 2010). The materials such as stainless steel, 
nitinol (Ni-Ti), cobalt-chromium (Co-Cr), etc.; are preferred (Lally, 2006) and these are 
corrosion resistant metal alloys. Merdan (2005) in his studies mentioned about biocompatible 
materials such as stainless steels 304 L, 304V, 316LV; mild steels, Ni-Cr-Fe alloys, platinum 
enriched stainless steels, and tungsten alloys. Iron and magnesium are considered as less toxic 

















Polymers are used as stent materials as they have viscoelastic properties. 
Polytetrafluroethylene (PTFE), ethylenetetrafluoroethylene (ETFE), fluorinated ethylene 
propylene (FEP), polyoxymethylene (POM), polybutylene terephthalate (PBT), polyether block 
ester, polyurethane, polypropylene (PP) are some of the polymer stent materials biocompatible 
with human body (Merdan, 2005). Some problems faced by polymer materials are bulkiness 
(Erne et al, 2006), low radial strength, inflammatory responses (Moravej, 2010), and low 
young’s modulus (Kranz, 1999). Hence, these are used as coatings on the surfaces of stents 
(Weber, 2003). Polymer coatings help in reducing the rates of thrombosis and neointimal 
hyperplasia (Bailey, 2009). The concern with polymer coatings is the loss of adhesion coating 
while crimping and unsheathing of stents (Roorda, 2007).  
Ceramics such as silicon nitrides, silicon carbides, silicon oxides, carbon nitrides, and 
calcium phosphates are used as stent materials (Kuehling, 2010). Ceramics are inorganic, hard, 
and strong materials. However, ceramics have low tensile strength and lead to crack propagation 
(Kranz, 1999). 
The stent materials are further classified according to the expandable states. There are 
two types of expandable mechanisms according to the stent materials. They are balloon 
expandable stents and self-expandable stents (Kanesaka, 1998). In balloon expandable stents, a 
balloon inflates and expands the crimped stent at the site and simultaneously expands the artery 
(Kanesaka, 1998). The concern with this type of stent is the balloon inflation pressure which 
expands the artery diameter. If the pressure applied to inflate the balloon exceeds nominal 
pressure, it causes vascular injury (Lau, 2004a). In self-expandable stents, the stent expands at 
temperature of about 37
0
C (Venkatraman, 2006). Nitinol is a self-expandable material; hence, 








deployment, balloon expandable stents exhibits plasticity and self-expandable stents exhibits 
elasticity (Lally, 2006 and Stockel, 2002). 
Stents are classified according to the coatings on the material. Stents with no drug 
coatings are called bare metal stents (BMS), and stents with drug coatings are called drug eluting 
stents (DES). Bare metals have higher restenosis rates; therefore research has introduced drug 
eluting stents (Luscher, 2007). Later, bare metal stents with thin struts had lower restenosis rates. 
(Vik-Mo, 2009). BMS are of two types, first generation (thick struts) and second generation (thin 
struts) (Dauerman, 2011). DES’s are classified as first generation (thick stents, thick polymers), 
second generation (biocompatible polymers, thin struts), third generation (bioabsorbable 
polymers) and fourth generation (disappearing, bio-degradable) stents (Dauerman, 2011). To 
improve the functionality of stents, drugs are used as anti-thrombogenic, anti-proliferative, anti-
inflammatory, anti-coagulants or cholesterol-lowering agents (Weber, 2003). A few drugs used 
on the DES’s are heparin, paclitaxel, sirolimus, zotarolimus and everolimus (Roorda, 2007). 
Iron works as a biodegradable material and also an important element in the human body 
(Moravej, 2010). Stents are expected to be biodegradable after the mechanical integrity is 
accomplished. These stents are required to support the artery for the duration of 6-12 months 
(Moravej, 2010) and in some cases the period from deployment to total degradation are 12-24 
months (Hermawan, 2010). Poly (L- lactide) or PLLA is a polymer used as a biodegradable 
material (Venkatraman, 2006). Magnesium alloy is good biodegradable material but degrades in 
short time (Moravej, 2010). Many investigations are carried on magnesium alloys because of 
potential accomplishment achieved with biodegradable materials i.e., restenting (Yun, 2009).  
The ability of mechanical support offered to the artery, depends upon material properties, 








in material selection process (Kranz, 1999). Some of the mechanical properties of materials 
consist of ductility, good elongation, high tensile strength, etc., (Poncin, 2003 and Moller, 1998). 
Table 1 summarizes the stent materials and their properties.  
Table 1 
Stent Materials and their Properties  
Metals Properties Alloys 
Stainless steel Passivative, corrosion resistant 316 L 
Nitinol Self expanding, super elastic, good MRI NiTi 
Titanium Passivative, less ductile  
Tantalum 
Passivative, highly ductile, corrosion 
resistance 
 
Nickel Highly toxic, inflammatory  
Chromium Highly toxic, inflammatory Co-Cr 
Magnesium 
Biodegradable, less toxic, immediate 
degradation, less ductile 
MgLi 
Gold Radiopaque  
Niobium Passivative  
Zirconium Passivative  
Source: Kranz, 1999; Lally, 2006; Hara, 2006; Koós, 2007; Bailey, 2009; Hermawan, 2010. 
The characteristics ideal stent flexibility, trackability, low profile, radiopaqueness, 
biocompatibility, high radial resistance, low metal density, good scaffolding, and 
thromboresistance (Lau, 2004b). Table 2 summarizes the characteristics and properties required 









Characteristics and Property of Stent Material  
Characteristic Property 
Corrosion Resistance High 




Yield stress High 




Restenosis rate Low 
Metal density Low 
Radial strength High 
Source: Stockel, 2002; Lau, 2004b; Lally, 2006.  
2.2 Clinical Performances 
In clinical performances, the safety and effectiveness of stents are observed after 
deployment. The observation period varies from 30 days to 5 years and depends on the factors 
affecting the stent performance (Groove, 2007 & Luscher, 2007). The performances of stents are 








2.2.1 Thrombosis. The formation of blood clots at the stent deployed site is measured as 
stent thrombosis and this could lead to failure of the stent efficacy and increase the rate of 
mortality (Luscher, 2007). Stent thrombosis is a common syndrome with the bare metal and drug 
eluting stents because of the platelet adhesion to the stent material (Cook, 2009 & Groove, 
2007). Hence, anti-platelet medications are prescribed to prevent the formation of blood clots 
(Cook, 2009 & Weber, 2003).   
2.2.2 Restenosis. The occurrence of re-blockage, because of the tissue growth or 
improper mechanical support offered by the stent at the afflicted site, is known as restenosis 
(Capelli, 2009 & Bedoya, 2006). Restenosis depends on the factors such as length of lesion, 
diameter of artery (Shedden, 2009), design of stent (Pant, 2011 & Lally, 2006), flexibility of 
stent and ratio of metal-to-artery (Capelli, 2009). Drug eluting stents with anti-proliferative 
agents help to lower the restenosis rates (Hara, 2006 & Weber, 2003). Neointimal hyperplasia is 
followed by restenosis (Pant et al., 2011 & Bedoya, 2006). 
2.2.3 Neointimal hyperplasia. Neointimal hyperplasia is the formation (growth) of 
tissue on the stent and re-blocks the passage. The high pressure applied on the artery during 
inflation lead to vascular injury (Hara, 2006 & Palmaz et al., 2002). This is one of the reasons 
which cause neointimal hyperplasia (Lally, 2006). Design (Butany et al., 2005), surface 
characteristics (Mani, 2007), radial force, and material selection (Taylor, 2001) are few aspects 
that lead to neointimal formation. 
2.3 Design Requirements of Coronary Stents 
Design plays a major role in stent performance. The design considerations for stents are 








minimal foreshortening, minimal elastic longitudinal recoil and optimal scaffolding (Lally, 2006 
& Gay, 2006).   
Stents are manufactured with a nominal diameter and then compressed to smaller 
diameter (crimped) to actuate through the passage to the lesion site and expanded to the size of 
nominal diameter (deployment) (Kuehling, 2010 & Gale, 2007).  
The expansion of the stent at the deployment site plays an important role as the diameter 
of the stent and the artery has to be equal after expansion (Etave, 2001 and Holzapfel, 2005). The 
outer diameter in an expansion state is 0.1 inch (2.5 mm), in a crimped state is 0.006 inch (0.15 
mm) and thickness between the walls is of 0.003 inch (0.08 mm) (Saunders, 2007). During the 
stent deployment procedure, internal diameter of the artery increases by 0.5 mm (i.e., from 2.5 
mm to 3 mm) (Capelli, 2009).  
The pressure applied to inflate the balloon inside the artery is 10-20 atm (Maguire, 2005).  
If the diameter of the stent is less than the diameter of the artery then the prevention of stenosis is 
halted. If the diameter of the stent exceeds the diameter of the artery then this leads to damage of 
the artery wall which is not expected during or after deployment of stent. The amount of pressure 
required for the expansion depends on the lesion type (Pericevic, 2009), stent material, and strut 
thickness (Etave, 2001). The pressure required to expand the stent is higher if the struts are 
thicker (Etave, 2001). The stiffness of the stent depends on the strut thickness (Holzapfel, 2005). 
A strut thickness of less than 100 µm shows better performance (Bailey, 2009). After 
deployment, a stent undergoes compressive pressure exhibited by the artery as the artery is 
elastic by nature (Etave, 2001 and Chua, 2004b). Hoop strength is another characteristic 
considered in the stent expansion. During expansion the stent is expected to have a high range of 








Hemodynamics is another important aspect acknowledged in studies. In this, the flow of 
blood through the stent passage is studied as the blood pressure in human body ranges between 
10 kPa and 16 kPa (Gideon, 2009). Stent performance can fail because of fatigue, as stent is 
designed to undergo 380 million cycles (10 years) before it leads to fracture (Lally, 2006). 
Testing the performance of the stents after deployment is not economical or an 
appropriate method, hence computational methods such as finite element analysis (FEA) studies 
have been executed to review the performance of the designs/products. Ansys is one of the finite 
element analysis software used for designing and simulation of the products. Some 
characteristics of stents that have to be considered while designing and simulation include outer 
diameter, inner diameter, strut thickness, strut width, strut length, number of struts, length, metal 
to artery ratio, foreshortening, recoiling and dogboning (Park, 2008 and Chua, 2004 b). The 
stress and strain characteristics are different for each material; hence the design has to be tested 
for each material (Kranz, 1999).  
The above mentioned characteristics of stents are evaluated by using simulation software. 
Park and Migliavacca (2008 & 2002) in their studies mentioned some formulae to calculate the 
following:  
2.3.1 Flexibility. The ability of the stent to pass inside the artery through the lesion area 
and this characteristic is calculated by 
    
   
  
      
 (1.1) 
EI - Bending stiffness, P –Pressure, L – Length of stent, δ – Deflection 
2.3.2 Radial stiffness. The support provided by the stent to the artery wall after the 
deployment of stent and this is given by 








Pinitial = Initial pressure, E.V. – Eigen value 
2.3.3 Longitudinal recoil. The ability of the stent to shorten after deployment and 
removal of balloon catheter is calculated by 
Longitudinal Recoil = 
              
     
   (1.3) 
Lload- is the length of stent before removing the balloon catheter. Lunload – a length of stent after 
removing the balloon catheter. 
2.3.4 Foreshortening. The ability of the stent to deform longitudinally after deployment. 
Foreshortening =  
         
 
    (1.4) 
L – Original length of stent, Lunload – Length of stent after removing the balloon catheter 
2.3.5 Radial recoil. The ability of stent to contract after the balloon catheter is removed. 
Radial Recoil =  
             
     
   (1.5) 
Rload- Radius of stent before removing the balloon catheter, Runload – Radius of stent after 
removing the balloon catheter 




               
     
    
       
       (1.6) 
Rload distal – Distal radius of the stent, R load central – Central radius of the stent 
2.3.7 Coverage area. The area between the arterial wall and stent 
Coverage Area = 
               
              
   (1.7) 
2.3.8 Target life. The fatigue durability to undergo cycling loads.  








The product life is considered to be 10 years i.e., 420,500,000 cycles of load. 
Stresses are formed when the stent is crimped, expanded during deployment, and 
compression exerted by the artery (Tan, 2001). The following formulae are given by Tan (2001) 
to calculate the circumferential stress in the stent. 
The circumferential stress in the wall of the stent is given by 
    
  
  
      (1.9) 
The above equation is given as   








    (2.10) 
where D = stent diameter, t = thickness, h = length of stent material, L = length of wire, d/2 = 
wire radius. 
The number of slots increase the expansion rate of the struts as large width have high 
elastic recoil and wide slots with narrow struts have less foreshortening (Chua, 2004 b). The 
stress concentration is high at the corners of slots during expansion and low at the middle of the 
struts and bridging struts (Chua, 2004 b). Considering all the above characteristics, the design 
plays a significant role in stent’s performance. 
2.4 Shape, Size and Structure  
Stents have various patterns and are classified according to diameter of stents, shape of 
struts, width, length and thickness of struts. Coronary stents usually have a length of 8-60 mm, 
diameter of 2.25-5 mm, strut width of 0.08-0.1 mm and thickness of 0.07-0.14 mm (Butany, 
2005). Stockel (2002) described the stents according to the shape of the struts as coiled, helical 
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Figure 6. Stent strut patterns (a) coil (b) helical spiral (c) woven (d) individual rings (e) 
sequential rings (source: Stockel, 2002). 
2.4.1 Coil. These stents are in coil form being that a flat wire turned into coil has high 
flexibility. However, the draw backs of these stents are low radial strength (Stockel, 2002) and 
high restenosis rates (Lally, 2006). A coiled stent is shown in the Figure 6 (a). 
2.4.2 Helical spiral. These stent struts are minimally connected to each other and they 









2.4.3 Woven. These stents are woven from wires and widely used as self-expanding 
stents as shown in Figure 6 (c). The advantage of these kinds of stents is the excellent 
mechanical support offered to the artery by covering the surface area by its braided wires. 
2.4.4 Individual rings. Individual rings with “V” shape struts are joined during 
manufacturing. Figure 6 (d) depicts the individual rings stent. 
2.4.5 Sequential rings. These rings are similar to individual rings but connected to rings 
with various shaped struts. This kind of stent is shown in Figure 6 (e). 
A brief description of stents available in the market with different materials, expansion 
types and physical characteristics are given in Table 3. 
Table 3 
Stents Available in the Market- Materials, Types and Physical Characteristics (Source: Butany, 






Type Physical characteristics Design 







Flexible radial “S” crowns and 
longitudinal “V” crowns 












Sinusoidal rings with round 
edges and rectangular edges are 
connected alternatively. These 
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Narrow sinusoidal rings 











Coil attached to a single 
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alternatively connected with  



































Zigzag rings with rounded 












Zigzag rings with rectangular 
edges connected with ‘U’ link 











Sinusoidal rings connected 









Sinusoidal rings connected 
alternatively to long and shorts 
crowns. The crowns are 











































Figure 7. Classification of stent manufacturing methods. 
2.5 Manufacturing Methods 
Stents are manufactured from several forms of materials such as machining from tubular 
forms, machining on the sheet, and later, the ends are attached by welding, rolling, etc., to form 
into a tubular form (Stockel, 2002). There are five forms of material recommended to 
manufacture stents by Stockel (2002) and Kuehling (2010). 
a) Forming from a wire 



































c) Rolling a design cut sheet 
d) Casting is pouring the stent material in indentations 
e) Vapor deposition 
Stents are manufactured in several methods and they are classified according to 
traditional and modern manufacturing methods. Some of them are laser cutting, electrical 
discharge machining, photochemical etching, rapid prototyping, casting as shown in Figure 7.  
Some of these manufacturing methods are described in this review. 
2.5.1 Laser machining. Laser cutting is most widely used manufacturing method in 
medical device industry because of its precision machining process (Caves, 2006). A high 
intensity beam of light operates according to the stent pattern to remove the material on a tubular 
blank. The material removal rate with the laser beam is about 0.1 to 0.5 µm of material for each 
pulse (Caves, 2006). The high intensity laser beam generates heat, forming oxide layers and 
burrs so the machining follows annealing, pickling, etching, de-scaling, polishing, cleaning and 
rinsing (Koós, 2007). There are various types of laser machining methods introduced in studies 






































Figure 9. Laser cutting with linear and rotary motors (adapted from Merdan, 2005). 
2.5.1.1 Laser cutting with computer numerical control (CNC) machine and pulse 
generator. In this manufacturing method, a rotatable collet fixture holds a mandrel positioned 
inside the work piece. For linear motion in x and y directions the machine controlled apparatus 
aligns on a CNC X/Y table and this table further acts as a base to support the equipment. A pulse 
generator connects the CNC controller and laser simultaneously (Shedlov 2005 & Saunders 
2007) as shown in Figure 8. The controller passes coded instructions and the work piece rotates 
accordingly under the laser beam to cut the material with precision. Laser beam with no pulse 
generators causes high heat and melts the work piece material. Therefore, ultrashort pulse lasers 
that produces short pulses i.e., less than 10
-11
 seconds are introduced (Weber, 2003). This makes 
a good surface finish and after machining surface treatments are insignificant (Weber, 2003). 
2.5.1.2 Laser cutting with linear and rotary motors. Merdan (2005) and Shedlov (2005) 
































stent. A common base on the bottom surface attaches the linear motor. On the top surface of this 
common base aligns the laser machine that remains stationary. This means, the components fixed 
on the top of the linear motor are stationary. The linear motor fastened above the carriage moves 
a longitudinally movable shaft with rotary motor in linear motion that is fastened below the 
carriage. The rotary motor holds the work piece and rotates it underneath the laser beam as 
shown in Figure 9. As the work piece rotates, it moves longitudinally and the laser beam cuts the 
tubular work piece in the desired pattern and the fluid aids to cool the work piece. The direction 
of the laser beam on the work piece changes with a preset tuning mirror. The fluid media 












Figure 10. Water jet guided laser machining (adapted from Sokolowski, 2007). 
2.5.1.3 Laser cutting with water jet. Richerzhagen (2004) explained this method as water 























In this method, the principle of total internal reflection utilizes water jet guided laser beam 
machining as shown in Figure 10. The water from inlet passes through the laser beam. The laser 
beam reflects internally in the stream of water and the water flows on to the work piece and the 
laser cuts the material in the preferred shape. The main advantage of this method is that the work 












Figure 11. Laser beam machining with gas (adapted from Momma, 1999). 
2.5.1.4 Laser cutting with gas jet. Momma (1999) explained this manufacturing method 
with a tubular metal work piece placed on a translation motion system. A metal tube affixes a 
stationary laser beam machine as shown in Figure 11. A gas nozzle between the beam and the 
work piece introduces oxygen gas. This oxygen gas from nozzle helps to melt the metal rapidly 
















disadvantage of this method is the formation of oxidation layers on the surface of the stent as a 
result of the practice of oxygen gas. 
2.5.2 Electrical discharge machining (EDM). In EDM, heat produces by the discharge 
of electrons. In this process, a dielectric fluid aids in electrical discharge to remove the material 
from work piece with the tool i.e., electrode (Theisen, 2004). The tool and conductive work piece 
immerses in the dielectric fluid (water or oil) and the power supply in the dielectric fluid 
produces sparks between the tool and the work piece. The dielectric fluid as well acts as a 
coolant and removes the debris formed throughout the material removal process (Roorda, 2007).  









Figure 12. Process flow of the EDM on metal foil to make a stent (Takahata et al, 2004). 
2.5.2.1 Microelectrodischarge machining (µEDM). Takahata (2004) explained µEDM 
stent manufacturing method with a metal foil as represented in Figure 12. This manufacturing 
method consists of 50 µm thick stainless steel 304 foil, µEDM, design pattern, and angioplasty 
balloon. The design pattern in this method has beams on two sides with a longitudinal axis. The 
two side beams connects three involute loops as shown in Figure 13. The µEDM process 
Metal Foil 
Machined with µ EDM with a sample 
pattern 
Balloon inflation makes the foil into 
cylindrical shape 
 
Placing angioplasty balloon with alternate 








machines the metal foil in involutes pattern. An angioplasty balloon inserts into alternate 
transverse bands of the foil and the inflation of the balloon expands the foil into cylindrical shape 









Figure 13. Involute loops formed on the foil by EDM (adapted from Takahata, 2004). 
2.5.2.2 Electrostatic discharge machining. Donadio (2000) explained this method as 
electrostatic discharge machine (EDM) with two charged electrodes to make the slots on the 
work piece. A holding device with a fixture clasps the work piece to rotate and shift towards 
charged electrodes. The two electrodes have different design profiles with definite geometrical 
angular notches as shown in Figure 14 (a) and (b). The first electrode has a rectangular extension 
notch with an angle of  82
0
 and width of 0.01 inches for the rectangular extension. The depth of 
the notch is greater than the radius of the tubular work piece because the charged electrode 
comes in contact with the work piece and cuts the slots. The second electrode has triangular 
notch with an angle more than 90
0
 and the depth of the notch is smaller than the radius of the 













piece on the other side. Simultaneously, another pair of similar electrodes positioned on the other 
side of the work piece cuts and generates the slots along with the first pair. The processed stent is 












Figure 14. Electrodes and machined work piece by electrostatic discharge forming method 
(adapted from Donadio, 2000). 
2.5.3 Hydro cutting. Roorda (2007) has stated several methods of manufacturing stents; 
one of them is the hydro cutting machining. This method introduces a jet stream with high 
intensity of water on the surface of the material to cut the material into slots. In hydro cutting, the 
material exposes to jet stream with abrasives such as garnet to form the slots. Apart from 
abrasives, hot water with chemical applications also promotes the cutting process. Sand blasting 
is a technique similar to water jet cutting except that sand is imposed instead of water. 
 
 






























Figure 15. Photosensitive chemical etching process (adapted from Trozera, 2003). 
2.5.4 Photosensitive chemical etching. Dustrude (1999) and Trozera (2003) explained 
this manufacturing method with tubular work piece, ultraviolet (UV) light, and transparent film. 
The procedure undergoes preliminary treatments such as electro-cleaning process to clean the 
work piece in a solution and application of a photosensitive resistance coat on the work piece. 
The apparatus consists of lamp with a UV wavelength, a sealed bulb with a filament, a 
platform with top plate and a slit to narrow the UV light. The setup is shown in Figures 15 and 
16. The tubular work piece installs a transparent film with specific design pattern on the top and 
aligns with a rotating member inside the hollow zone. The UV rays from the light source exposes 
the work piece and this endows photo sensitive resistance coat on the material to react and 
























electrochemical etching treatment to form the stent structure. The transparent film connects to a 
weight to provide tension and consecutively to uphold proper contact with the work piece.  
The UV light ranges between 360 and 440 nanometers with a wavelength of 390 
nanometers. The chemical etchants essentially use Ferric chloride at a grade of 36- 42 degrees, 
Baume at 125
0
 F, and 5 volumes of HCL solution i.e., 1 volume of HCL, 1 volume of nitric acid, 













































Figure 17. Braiding machine with yarn and wire to form tubular stent (adapted from Jayaraman, 
2002).  
2.5.5 Wire braiding. Jayaraman (2000) illustrated this arrangement as the braiding 
machine with spools of yarn and a spool of reinforced wire. The spools provide yarn and 
reinforced wire to the knitting machine as shown in the Figure 17. The machine has an intake 
section and weaves all the strands accordingly. The number of spools of yarn has to be more 
compared to spools of wire i.e., 2:1 ratio has to be maintained all the time in this process.  
The break mechanism connects the spool of wire and inactivates whenever the wire is 
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employed for yarns are natural fabric, polyester, polypropylene, polyethylene and for wire are 
metal alloys. 
2.5.6 Electromagnetic forming. The apparatus consists of forming coil (electromagnetic 
generators), energy storage capacitors, power supply, conductive metal object (work piece) and 
field shape mandrel. The energy storage capacitor connects power supply and forming coils. The 
work piece and field shape mandrel are positioned between forming coils as described by Baum 
(2007) and the apparatus is shown in Figure 18. The forming coil generates electromagnetic 
pulses from the capacitors and the work piece (conductive material) thus induces eddy currents. 
The magnetic field from the forming coil and eddy currents from work piece interacts with each 
other and leads to formation of repulsions between them. These repulsions simultaneously lead 
to stress formation and deform the metal permanently. The field shape mandrel helps to cut the 








Figure 18. Electromagnetic forming: apparatus manufacturing medical stents (adapted from 
Baum, 2007). 
Figure 19 shows a hollow work piece with plurality of holes placed inside the tubular 
work piece and the whole set up is placed between coils. As the coil produces electromagnetic 
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field, the work-piece forms eddy currents and this leads to repulsions. These two form a 
mechanical force towards the center of mandrel. This force leads to formation of holes on the 
work piece. 
Additionally, the EMF method fabricates sheet metal pieces in similar manner and joins 
the sheet by one of the methods such as gas welding, electron beam welding, soldering, brazing, 









Figure 19. Tubular work piece with EMF procedure (after Baum, 2007). 
2.5.7 Casting. Casting is an ancient method of fabrication, associated with molds and 
molten material. The molten material fills the mold and solidifies to form a pattern/structure. The 
method is set forth to fabricate stents. There are several methods of casting and few of them are 
described in the following sections. 
2.5.7.1 Centrifugal casting. The equipment includes casting flask and female mold as 
shown in Figure 20. Mirizzi (2003) illustrated the method with a female mold assigned in the 
casting flask. The screws fasten the mold and flask tightly and molten material fills the mold. 



















mold cavity. A female mold consists of grooves which lead to formation of the stent structure. 
The mold rotates to spread the casting material equally into the grooves. The rotational force 
accelerates high velocity and institutes centrifugal force. This centrifugal force allows the 
casting/molten material to move radially outwards i.e., into the grooves of the mold. This also 










Figure 20. Centrifugal casting method (adapted from Mirizzi, 2003). 
2.5.7.2 Pouring the stent material in the indentations/ grooves. One of the procedures to 
manufacture stents is deposition of the stent material on a sacrificial structure (SS). Fabrication 
materials of SS are sugar, starch, ice, wax, polyvinyl alcohol and polyvinyl acetate materials that 
dissolve in water (Roorda 2007 & Weber 2004). The composition of SS is accomplished from 
injection molding, extrusion, laser ablation or by prototyping techniques.  
The negative stent/ SS have indentations or grooves. The molten material either 
introduced by spraying or coating fills these indentations or grooves. The other method is to dip 




















manufacturing method is explained by Weber (2004) and Figure 21 (a) and (b) depicts the 
materials poured in indentations/grooves. This method integrates desired mechanical 
characteristics as the indentations fill the layers with different kinds of materials. Different layers 
of materials include thermoplastic/thermosetting polymers, biodegradable polymeric materials, 












    (b) 
Figure 21. Pouring stent material in the indentations or grooves (adapted from Weber, 2004). 
Likewise, electrochemical deposition method engages SS made of copper to form stent 
material. After formation of stent, the copper material dissolves in solvent (Moller 1998). The 
stents manufactured by casting have normal flow passage and expansion state as other stents 
manufactured by various methods. 
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Figure 22. Rapid prototyping method (adapted from Roorda, 2007). 
2.5.8 Rapid prototyping. The setup consists of inkjet printer, cartridge, powder delivery 
system and fabrication system. Figure 22 depicts the prototyping process. Roorda (2007) 
illustrated the process with inkjet line from cartridge that carries ink to the inkjet printer head. 
The powder delivery system has a powder delivery chamber with a piston and the chamber is 
filled with ceramic powder/metal. The piston moves upward to deliver the powder layer by layer 
to the fabrication system. The fabrication system has a fabrication chamber with a piston. The 
roller helps to roll the powder from powder delivery system to the fabrication system. The inkjet 































each layer the fabrication system piston moves downward and the powder is bound by the fluid 
from the inkjet. The layers of the powder bind and harden to form the stent.  
The pores present on the stent separate the unbound ceramic powder and the cleaning 
process clears the unbound powder on the stent. 
2.5.9 Vapor deposition. Vapor deposition consists of evaporation, sputtering, ion beam 
assisted deposition and chemical vapor deposition methods. The source material deposits layer 









Figure 23. Vacuum deposition by evaporation (adapted from Whitcher, 2005). 
2.5.9.1 Evaporation process. Whitcher (2005) demonstrated the evaporation process as a 
chamber with rotary motor, mandrel, source material and vacuum. Figure 23 represents the 
evaporation process equipment. The set up allocates the mandrel on the rotary motor and it 
rotates in the direction of vector with a speed of 1-60 rev/min. Vacuum fills the chamber and 
develops appropriate vacuum pressure. The source material flows from top of the chamber 
















material deposits on the mandrel. Drilling, cutting or other machining processes separates the 











Figure 24. Vacuum deposition by ion beam (adapted from Whitcher, 2005). 
2.5.9.2 Ion beam process. The set up consists of filter and templates organized in a 
chamber. In this method, the filter prevents the contaminants from the source material or 
separates the isotopes of an element. The templates help to narrow the path of isotopes and allow 
a single isotope to pass towards the mandrel and form a layer on it. Whitcher (2005) elucidated 
the ion beam process as shown in Figure 24. The separation of the mandrel and material take 
place after sufficient amount of material deposits on the mandrel. Cutting, milling, grinding, 
drilling or laser cut procedures executes the separation process.  
Pattern mask/reverse image on the mandrel serve in the formation of struts. The pattern 
mask on the mandrel allows the material to deposit in the slots. After formation of thick layers of 




















material. Vapor deposition method provides the solution to obtain multiple layers of the material 
with mechanical and biocompatible properties. In this manufacturing method, cleaning process is 
inessential but follows the chemical etching or polishing procedures to remove imperfections on 
the material. 
Table 4 illustrates the advantages and disadvantages of the manufacturing methods of 
stents. 
Table 4 
Advantages and Disadvantages of Manufacturing Methods  
Manufacturing Advantages Disadvantages 
Laser machining Precision cut 
Expensive, compulsion of 
surface treatment technique 
Electro discharge 
Machining 
Smooth surfaces  
Hydro- Cutting 
Cold shaping, no chemical reactions and 
flame 
 
Braiding Highly flexible, cold working 
Complications in forming 
complex patterns 
Vapor deposition 
Desired compositions, mechanical 
properties, geometries and surface 
smoothness are obtainable. 
 
 Source: Moller 1998; Trozera 2003; Witcher 2005; Roorda 2007. 
2.6 Conclusion 
This chapter reviewed the material characteristics, design patterns, design functionality 
and some of the manufacturing techniques that are practiced in developing stents. The review 









The formation of plaques inside the arteries varies from person to person and clinicians 
have to select the appropriate stent to be deployed in the artery (Tan, 2001). Although there are 
many stents available, because of the complex lesions, there is a need for new designs. So, 
manufacturers and clinicians focus on explorations of new stent designs. Thus, this research 
concentrates on product development methodology of stents to develop and test new designs. 
Chapter 3 incorporates all the information necessary for product development of coronary stents 
























Methodology for Product Development of Coronary Stents 
3.1 Problem Statement 
Over the past 25 years, many stent designs have been developed and these are available 
for use in the market. Even though there is ample selection of stents, the medical device 
industries still explore for new designs to operate the complex lesion structures. Clinicians and 
medical device manufactures look for new stent designs or to improve the existing designs to 
deploy the stents successfully in the torturous lesion arteries. To develop new designs or to 
improve the existing stent designs in functionality aspects, product development methodology 
with phases is essential. The functionality aspects include materials, pattern, geometry, 
simulation tests and manufacturing methods. The research in the past has concentrated in all the 
functionality aspects, but until now no research has initiated product development methodology 
for coronary stents.  
The methodology is essential to consider all the phases of product development at 
conceptual stage. This consideration directs the decision making process that lead to cost- 
effective and time conservation practices. Thus, this research develops a new product 
development methodology of coronary stents for complex medical needs and analyses the 
methodology by modeling novel stents and compares the results with Cypher stent (J & J Co.). 
3.2 Research Objective 
The stages of product development of coronary stent from concept to deployment in the 
in the patient are critical. These stages with development methods influence decision making and 








evaluation of the concepts is extremely significant. The research identifies this significance and 
develops a methodology for coronary stents. 
The objective of this study is to develop a new methodology for coronary stent product 
development with emphasis on design, simulation and manufacturing. The new methodology 
compels multiple schemes of engineering design disciplines upon coronary stent product 
development to endeavor adaptable and cost-efficient techniques. This product development 
approach for coronary stents is presented with design, simulation and optimization strategies and 
these are described in detail.  
3.3 Development Strategy  
Product development generally includes introduction of a new product in the market or 
accompanies some new features to existing products (Santos, 2011). Product development 
includes market research to accumulate customer’s needs, research and development to make 
product design with simulation and to manufacture the prototypes for bench testing, product 
manufacturing and deployment in the market. The product development prototypes and tests 
utilize CAD and FEA software to design and simulate the functionality. These help to rebuild 
and optimize the product in terms of quality and reliability. 
Product development usually takes approximately 6 months to 10 years to build a product 
from idea to deployment in the market. The enormous time frame of product development life 
cycles requires the need for concurrent engineering. In concurrent engineering (CE), all the 
phases of product development are considered at the concept stage to economize time and 
resources. This necessitates the involvement of all departments to generate ideas to satisfy 
customer’s quality requirements, availability of resources and economical resources. The 








appropriate costs and time frames. The general view of product development is shown in Figure 
25 and the arrow around depicts the decisions flow throughput of all departments during concept 





Figure 25. General view of product development. 
Product development of coronary stents include concept generation, voice of the 
customer (Santos, 2011), product design in computer aided software, product performance test in 
finite element software, prototype tests, selection of manufacturing method (Kamrani, 2006), 
Food & Drug Administration (FDA) approval to conduct in-vivo experiments, performance 
results of in-vivo tests, FDA approval and insertion of the medical devices in patients (Kaplan, 
2004). The time frame of product from its concept stage to prototype testing stage approximately 
classifies 2-3years (Kaplan, 2004). Medical device placements in patients follow clinical studies 
for 24 months’ time frame (Kaplan, 2004).  
3.4 Methodology Structure   
The product development process flow of coronary stents is shown in Figure 26. First, the 
process develops stent concepts to prevent the blockages in the arteries. These concepts with 
sketches are designed in designing software and tested in simulation software. The data is 
analyzed from the simulation results and then manufacturing techniques are scrutinized to select 
an optimized manufacturing technique for the stent design. A prototype of the stent is 
















functionality of stents is tested by conducting the in vivo experiments. Finally, FDA clearance is 
obtained to deploy the stents in patients and clinical outcomes are studied. From Figure 26, the 
product development process flow evidently corresponds to the information and decision flow. 
The design changes whenever there is performance problem and the information of these 
changes and further study are carried to design stage. The prototype testing problems are carried 
to manufacturing feasibility stage to address the surface treatments necessary to enhance the 
performance of the stent performance. 
In this research, the product development methodology of coronary stents with 
prominence on design, simulation and manufacturing is proposed. Refer to Appendix A for 
paradigmatic model of product development methodology of coronary stents. 
Design and simulation are further classified as conceptual design and detailed design 
phases. The conceptual design phase comprehends the concepts to build the stent platform. This 
phase includes the material, form, pattern, geometry, coating and designing software.  
Detailed design phases include performance of the stent inside the artery, stress and strain 
during crimped and deployment stages, and software for simulation. The detailed design phase is 
not limited to the above simulation aspects, but includes a wide range of tests such as dogboning, 
recoiling, foreshortening, longitudinal recoil, flexibility, coverage area, fatigue analysis, etc.  
The study further reviewed manufacturing techniques; these are classified as traditional 
and modern techniques. The stent designs are assessed for manufacturing feasibility by 
reviewing manufacturing techniques, such as: laser machining, electromagnetic forming, rapid 
prototyping, casting, etc. The traditional manufacturing techniques constitutes of casting, 
forming, sheet metal processing, braiding, surface treatment and joining. Modern manufacturing 








comprise of water jet cutting, vapor deposition and electrical magnetic forming, photo chemical 
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The deployment/delivery system consists of guide wire, catheter, stent mounted on 
balloon, balloon inflation system and pressure gauge. These are possible considerations in the 
methodology but the study is restricted to stents and deals with the characteristics stated in the 
above sections. 
3.5 Application of Product Development Methodology 
The methodology introduced in this chapter takes advantage of the conceptual design 
phase and detailed design phase to develop novel stent designs. The methodology is reviewed by 
constituting novel coronary stent designs and performing simulations with various materials such 
as stainless steel alloy, cobalt-chromium alloy, magnesium alloys; and comparing the results 
with Cypher stent (Johnson and Johnson Co.). The simulations with different materials carried 
out on the novel stent designs help to understand the design and its functionality. Figure 27 
represents the multiple schemes of design, simulation and testing of the novel designs. The bi-
directional arrows represent design, simulation and testing decisions and repetition of the 
processes. 
                      
Figure 27. Design, simulation & testing-product development scheme (Vaizasatya, 2013). 
The stent designs are modeled in Solidworks 2013 (Dassault Systèmes SolidWorks Corp, 
Massachusetts, USA) and transferred to Ansys Workbench 14.0 (ANSYS, Inc., Pennsylvania, 










The stent designs assume crimped state diameters with no balloon, artery and plaque 
environments for the analysis. In this study, the considerations such as material, surface contacts 
and friction information for balloon, plaque and artery are neglected because of sole 
concentration on stents. 
Recently, the studies on stent materials have been inclined towards biodegradable stents 
because of the possibilities of impermanent stents in the arteries. Magnesium is considered as 
highly biodegradable material. Hence, this study concentrates on magnesium alloys for novel 
coronary stent designs. These stent designs are introduced and explained in chapter 4, and 






















Innovative Coronary Stents Design 
4.1 Overview 
Stent design plays a major role in success of stent performance. Poor performance leads 
to restenosis, neointimal hyperplasia, thrombosis and restenting. Conceptual design phase 
includes material, form, pattern, geometry and coating. In this study, the concepts are adopted to 
design three novel stents and these designs are modeled in CAD software i.e., Solidworks. 
Pattern and geometry of the novel designs are emphasized in this chapter. 
4.2 Design Thoughts and Methods 
Design of the stent plays an important role in flexibility, functionality, metal to artery 
ratio and radial force required to deploy the stent. The novel stent designs introduced in this 
research are a combination of closed and open cell slots connected to sinusoidal links or 
connectors. The three novel designs 1, 2 and 3 are designed in Solidworks 2013. Solidworks is 
computer aided design software supports to design 3-D models with geometric dimensions. The 
designs are modeled in crimped state with 1.5 mm diameter. The description of patterns, 
dimensions and 3- D designs of stents 1, 2 and 3 are described in the following sections. 
4.2.1 Design 1. This design with diamond shape strut connects two marquise (elliptical 
with sharp edges) shape struts as depicted in Figure 28 and each diamond shape strut connects a 
sinusoidal link. This design in expanded circumferential form shows the number of crowns in a 
stent design as shown in Figure 28. For detailed geometrical dimensions refer to Appendix B, 
















Figure 28. Design 1. 
                                                    
                                               (a)                                                       (b)                                         






     
 










4.2.2 Design 2. The struts with solid ‘X’ connect sinusoidal links and ‘v’ extension struts 
connects the preceding rings of the stent. The ‘X’ pattern struts have a circular hole at the center. 
This stent design in expanded circumferential form is shown in Figure 30. Figure 31-(a) & (b) 
shows design 2 in 3-D form. Refer to Appendix B, Figure B.2 and Table B.2 for geometrical 
dimensions of design 2. 
                   
                                              (a)                                                         (b)                                         








Figure 32. Design 3. 
4.2.3 Design 3. The struts with ‘X’ connect sinusoidal links and ‘v’ extension struts 









and rectangular slots on the extensions. This stent design in circumferential expansion form is 
shown in Figure 32. Figure 33-(a) & (b) shows design 3 in 3-D form. For geometrical 
dimensions illustration of design 3, refer to Appendix B, Figure B.3 and Table B.3. 
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Figure 34. Cypher design.  
4.2.4 Cypher stent. Cypher stent is a coronary stent with optimal design characteristics 
on the market, manufactured by Johnson & Johnson Co. In this research, Cypher stent represents 










Cypher stent has inverted ‘U’ shape struts connect alternatively with sinusoidal connectors to 
link the preceding rings. The stent design in expanded circumferential form is shown in Figure 
34. Figure 35-(a) & (b) shows the design in 3-D form. For detailed geometrical dimensions of 
Cypher stent, refer to Appendix B, Figure B.4 and Table B.4. 
                          
                                                  (a)                                               (b)                                         
Figure 35. 3-Dimensional Cypher stent. 
4.3 Conclusion 
This chapter introduced three novel stent designs built from conceptual design phase of 
product development methodology. The designs are modeled in Solidworks software with more 
detailed geometrical dimensions. The structures of the stent designs are elaborated and in chapter 
5. These designs are simulated using Ansys Workbench, finite element analysis (FEA) software 













Design Simulation Results and Discussion  
5.1 Overview 
Stent designs introduced in the previous chapter are imported to Ansys Workbench 
software to perform simulation of designs for stress, strain and total deformation analysis. Ansys 
Workbench software provides FEA modeling, meshing and design analysis i.e., simulation of 
complex structures/designs. In this study, two types of simulations are performed on the stents. 
One is testing the novel designs to compare with a stent available in the market i.e., Cypher stent 
(J & J Co.). Second is testing the novel designs with magnesium alloys. The procedure and 
results of these simulation tests are discussed in the following sub-sections. 
5.2 Simulation Process 
Simulation is creating the real world environment to test the functioning of structures/ 
designs. Simulations are carried by importing and generating the designs to Ansys Workbench 
14. The designs of stents are modeled in Solidworks 2013 and the files are converted to IGES 
file extensions, which makes easier to import and read in FEA software. Simulation consists of 
material properties, fine mesh generation, application of boundary conditions, and post 
processing analysis. The simulation processes of the novel stent designs are further explained in 
detail. 
5.2.1 Material properties. The designs are tested with various materials such as, 
stainless steel, cobalt-chromium and magnesium alloys. The properties that are considered for 
materials are Young’s modulus, Poisson’s ratio and yield strength. Each material property is 
mentioned in Table 5 and the values of the materials are utilized to test the stent designs. The 









Material Properties  



















243000 0.3 671 1150 9100 
Magnesium – 
WE43 
44000 0.3 160 270 1830 
Magnesium– 
AZ31 
45099 0.3 138 276 1830 
Magnesium – 
AZ80 
45157 0.3 234 354 1830 
Magnesium – 
ZK60 
45383 0.3 228 304 1830 
Source: Poncin, 2003; Mani, 2007; Hermawan, 2010; Gastaldi, 2011. 
5.2.2 Mesh design. Mesh is generated for the designs with triangular elements and each 
triangular element has 3 nodes. The number of nodes and elements formed during mesh 
generation for stent designs 1, 2, 3 and Cypher are presented in Table 6. The designs are finely 









    
                         (a)                                (b)                                  (c)                             (d) 
Figure 36. Mesh generation.  
Table 6 
Number of Nodes and Elements of Stent Designs 
Design No. of Nodes No. of Elements 
1 9075 3681 
2 26194 12247 
3 37901 16999 
Cypher 7611 2633 
 
5.2.3 Boundary conditions. Simulation of design involves applying boundary conditions 
as inputs. In this study, displacement and pressure are applied as boundary conditions. 
Displacement of 1.5 mm is applied in X-direction in cylindrical coordinate system as shown in 
Figure 37- a, b, c and d. This ensures the stent to expand radially in X-direction. A pressure of 
10-20 atm is applied gradually in radial manner on the stent to deploy the stent to 3 mm diameter 










                          (a)                                 (b)                               (c)                            (d) 
Figure 37. Boundary condition-displacement. 
       
                           (a)                                (b)                            (c)                            (d) 
Figure 38. Boundary condition-pressure. 
5.2.4 Post processing. The simulations of stent designs are carried after mesh generation, 
application of boundary conditions and material properties. The designs are tested for von Mises 
stress, strain and total deformation. Designs 1, 2, 3 and Cypher stent with stress, strain and total 
deformation analysis are shown in Figures 39, 40, 41 and 42 respectively. The simulation results 
of design 1, 2 and 3 are compared with Cypher stent and the performance of each stent design 








                             
                     (a)                               (b)                              (c) 
Figure 39. Equivalent (von Mises) stress, strain and total deformation. 
                   
                   (a)                                 (b)                                (c) 
Figure 40. Equivalent (von Mises) stress, strain and total deformation. 
 
   
         (a)                                       (b)                                    (c) 
Figure 41. Equivalent (von Mises) stress, strain and total deformation. 








                                                                            
    (a)                                  (b)                               (c) 
Figure 42. Equivalent (von Mises) stress, strain and total deformation. 
5.3 Mass and Volume  
The application of material properties on the stent designs in Ansys software provides 
mass and volume parameters of the stents. The mass and volume data of stent designs are 
provided in Appendix C, Table C.1 and Table C.2 respectively. 
 
Figure 43. Mass of stent designs. 
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Figure 43 depicts the mass values of design 1, 2, 3 and Cypher stents. These values are 
compared with stainless steel, cobalt-chromium and magnesium biomaterials. The stents with 
cobalt-chromium has highest mass followed by stents with stainless steel. Stents with 
magnesium have low mass values as the density of the material is lowest compared to other two 
materials. Designs 2 and 3 have higher mass compared to other designs. Volume of the stents is 
shown in Figure 44. Cypher has lowest volume compared to other designs and design 3 has 
highest volume. High density materials such as cobalt-chromium are good to design thin strut 
stents. The biomaterial has low amounts of stainless steel composition, so it is MRI compatible 
as well as radiopaque.  
5.4 Results and Discussion 
The research conducts simulation analysis during the deployment state of stents. The 
simulations are carried to test two types of performances of novel stent designs. The two tests 
are:  
i) Comparison of the results of von Mises stress, strain and total deformation of  
         novel designs with the results of Cypher stent. 
ii) Comparison of the von Mises stress, strain and total deformation of novel designs  
        with significant magnesium alloys. 
5.4.1 Stress/strain analysis and comparison with Cypher stent. The biomaterials 
considered in this analysis are stainless steel 316L, cobalt-chromium L605 and magnesium 
WE43. The novel stent designs results are compared with Cypher stent results. Cypher stent is 
made of stainless steel 316L but analysis is conducted with different biomaterials to compare the 










Figure 45. Comparison of von Mises stress with Cypher stent. 
The results of stress, strain and total deformation of designs 1, 2, 3 and Cypher at 1.01-
2.03 MPa pressures are provided in Appendix D.  
 
Figure 46. Comparison of von Mises strain with Cypher stent. 
Figure 45 displays the von Mises stresses at 2.03 MPa pressure. In Figure 45, the stress 
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WE43. All the designs with magnesium WE43 have almost same values of stress i.e., 265 MPa. 
Magnesium stents have significantly lower than stainless steel and cobalt chromium stents. The 
stress values of the stents are approximately equal to or higher than the yield strength values of 
the respective materials. Although, the designs with cobalt-chromium have high stress values, 
the values are between yield strength and ultimate tensile strength values of the material. 
The strains of designs at 2.03 MPa are shown in Figure 46. Designs with magnesium 
have higher strain values compared to stainless steel and cobalt-chromium biomaterials. Designs 
with low strain values show better performances. Here, the stent designs with stainless steel and 
cobalt-chromium shows good results.  
 
Figure 47. Comparison of  total deformation with magnesium WE43  
Flexibility is another parameter that significantly affects the functionality mechanism of 
stents. This parameter of the material influences the total deformation of the stents from crimped 
state to deployment state (i.e., 1.5 mm-3.0 mm). The total deformation of stent designs are 
shown in Figures 47, 48 and 49 for cobalt-chromium, stainless steel and magnesium 
biomaterials. These graphs show that designs 2 and 3 have constant deformation values during 
the application of pressures from 1.11-2.03 MPa for all the biomaterials. Design 1, gradually 

































deformation values for SS and Co-Cr. Cypher stent has significant behavior compared to other 
designs as deformation gradually increased with the increase in application of pressure for all 
materials. Designs with different biomaterials have different deformation values but gradual 
increase in deformation is preferred in order to prevent vascular injuries while deploying stents 
in the arteries. 
 
Figure 48. Comparison of  total deformation with stainless steel 316L. 
 
Figure 49. Comparison of  total deformation with cobalt-chromium L605. 
From stress, strain and total deformation graphs, Cypher with SS and Co-Cr has good 





























































Figure 50. Comparison of  stress with magnesium alloys 
 
Figure 51. Comparison of  strain with magnesium alloys. 
5.4.2 Stress/ strain analysis of designs with magnesium alloys. Novel designs are 
tested with magnesium alloys WE43, AZ31, AZ80 and ZK60. The results are compared to 
summarize the performance of stents with magnesium alloys and to select best magnesium alloy. 
Designs 1, 2 and 3 are analyzed with magnesium alloys and stresses graph is shown in Figure 50. 
From the graph, the designs have stress values between yield strength and tensile strength of 
















































designs with magnesium AZ80 has higher stress values compared to other material designs. The 
trend is same for the strain values of the designs. The strains of the designs are shown in Figure 
51. 
 
Figure 52. Comparison of  total deformation with magnesium WE43. 
 
Figure 53. Comparison of  total deformation with magnesium AZ31. 
The total deformation values of the stent designs for magnesium alloys WE43, AZ31, 
AZ80, ZK60 at 1.11-2.03 MPa are shown in Figures 52, 53, 54 and 55 respectively. In all the 
























































gradually increased with the increase in pressure. The deformation values of design 1 for 
materials AZ80 and ZK60 are constant for few pressure values but gradually increased with 
increase in pressure. 
From the total deformation graphs of magnesium alloys, design 1 with WE 43 and AZ 31 
alloys show promising results i.e., gradual deformation with increase in pressure. 
 
Figure 54. Comparison of  total deformation with magnesium AZ80. 
Design1 with magnesium WE43 and AZ31 biomaterials are recommended from the 
stress, strain and total deformation results. 
From the two types of simulation tests conducted in this research, it reveals that different 
struts structures behave distinctly with the application of same magnitude of pressure. This study 
has considered the deployment state of stents; however, the stents has to be evaluated in crimped 


































Figure 55. Comparison of  total deformation with magnesium ZK60 
5.5 Conclusion 
The designs are tested with bio-materials and compared with Cypher stent. The amount 
of pressure applied radially on the stents is same, but the strut designs are distinct for each stent 
design. So, the behavior of the stents changes with different patterns of designs. From the results 
it is recommended to have design 1 with magnesium WE43 or AZ31. The methodology 
introduced in this research is tested with few aspects of coronary stents. However, the designs 
have to be analyzed with parameters such as foreshortening, dogboning, radial recoil, 
longitudinal recoil and coverage area. The simulation software provides cost effective solutions. 
Hence, the research in the future could be concentrated on above aspects. Conclusions and future 




































Conclusion and Future Work 
6.1 Research Overview 
Product development methodology is essential for any class of products to understand the 
concepts and resources necessary in an industry. The methodology composes of market or 
consumer needs, concepts, material requirements and feasible resources to optimize time, cost 
and quality of the products and to deploy the product in the market within short time frame. This 
concept is widely known as concurrent engineering; in which all the phases of the product are 
considered during idea generation stage to condense the lead time and opt for cost efficient 
techniques. 
 Hence, this study contributes product development methodology of coronary stents 
composed with concepts and resources to enhance decision making processes and to promote 
time efficient methods. The new methodology acknowledges the conceptual design phase, 
detailed design phase and manufacturing processes of coronary stents. 
Conceptual design phase includes material, form, pattern, geometry, coating and 
software. Detailed design phase involves with crimping, deployment, performance and software. 
Manufacturing processes are compromised of traditional and modern methods. All these phases 
are considered during the introduction of stent concepts i.e., product development phase to 
optimize time and cost.  
6.1.1 Execution of Methodology. The conceptual design phase and detailed design phase 
of product development methodology are executed by adopting the concepts to design and 








The designs are modeled with crimped diameter in Solidworks software and simulated in 
Ansys Workbench software. These stent designs are simulated with biomaterials such as 
stainless steel 316 L, cobalt-chromium L605 and magnesium alloys.  
Restenting is possible with a biodegradable material and magnesium is a leading 
biodegradable material. Hence, various magnesium alloys are considered to evaluate the novel 
stent designs in this study. The research is conducted to select the appropriate magnesium alloy 
so; the variations in strut designs and materials are simulated and optimized using Ansys 
software.  
The novel designs are compared with Cypher stent (Johnson & Johnson Co.) results and 
design 1 with magnesium WE43 or AZ31 are recommended from the study of simulation results. 
These materials have shown better results compared to other materials. 
Many manufacturing methods are described in the methodology and water jet laser 
manufacturing method is encouraged because of the precision cut and elimination of surface 
treatments as this method is free from formation of oxidation layers and burrs.  
6.2 Future Work  
 A detailed research on the following aspects of stents is required to assess the product 
development methodology introduced in this study. 
6.2.1 Crimping. Although most studies introduce the stents designed in crimped state, 
these could be designed in expanded state i.e.., 3 mm and perform the simulation procedure by 
crimping the stents to 1.5 mm. During this course, the study helps to observe stent behavior 
parameters such as stress, strain and total deformation. 
6.2.2 Strut connectors. The novel stent designs could be improved by remodeling with 








6.2.3 Biodegradability. Simulation studies could be conducted to perform the analysis 
on the materials to address the time frame of the biodegradability of magnesium alloys.  
6.2.4 Functionality evaluation. Researchers engage in evaluating the parameters of 
stents such as dogboning, foreshortening, longitudinal recoil and radial recoil. These parameters 
are evolved during deployment procedure hence; artery and plaque could be added to the 
simulation environment to study the functionality of the stents. The parameters discussed here 
are affected by metal-to-artery ratio factor. This is also a primary aspect considered to prevent 
thrombosis after deployment of stent. 
6.2.5 Fluid flow analysis. This analysis involves with an artery and plaque in the 
simulation environment. The analysis could be conducted to study the flow of fluids/blood along 
with the amount of drug release.  
6.2.6 Transient analysis. The above mentioned finite element analyses could be 
performed as function of time. 
6.2.7 Prototype evaluation. Prototypes can be manufactured and tested with different 
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Form Wire, Tube, 
Ribbon, Sheet 
Pattern 
Rings, Helix, Coil, 
Unconnected, Open Cell, 
Closed Cell, Hybrid, 







Geometry Stent length, strut thickness, 
strut width, strut length 
Manufacturing 
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Figure B.1. Design 1. 
Table B.1. 
Geometrical Dimensions of Design 1 

































Figure B.2. Design 2. 
Table B.2. 
Geometrical Dimensions of Design 2 











































Figure B.3. Design 3. 
 
Table B.3. 
Geometrical Dimensions of Design 3 







































Figure B.4. Design 4. 
Table B.4. 
Geometrical Dimensions of Cypher 




























Mass of Stents (Kg) 
Material Design 1 Design 2 Design 3 Cypher 
Stainless steel- 316 L 0.000000762 0.000000882 0.000000974 0.000000614 
Cobalt- chromium- L605 0.000000866 0.000001003 0.000001108 0.000000699 









Design 1 0.09519 
Design 2 0.11025 
















Stainless Steel (316 L). Cobalt- Chromium (L605) and Magnesium alloys: Stress, Strain. Total 
Deformation values of Stent Designs 1, 2, 3, & Cypher. 
Design 1. 
Table D.1. 
Stainless Steel - 316 L 
 
Table D.2. 
Cobalt- Chromium – L 605 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 1128.7 0.0047325 0.5724 
1.11 1128.7 0.0047325 0.5739 
1.21 1128.7 0.0047325 0.5739 
1.31 1128.6 0.0047325 0.5739 
1.41 1128.6 0.0047325 0.57238 
1.51 1128.6 0.0047325 0.57238 
1.61 1128.6 0.0047325 0.57237 
1.72 1128.6 0.0047325 0.57237 
1.82 1128.6 0.0047325 0.57236 
1.93 1128.6 0.0047325 0.57236 
2.03 1128.6 0.0047325 0.57236 
 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 628.43 0.0032953 0.57219 
1.11 628.43 0.0032953 0.57218 
1.21 628.49 0.0032953 0.57211 
1.31 628.49 0.0032953 0.5721 
1.41 628.49 0.0032953 0.5721 
1.51 628.46 0.0032953 0.57213 
1.61 628.46 0.0032953 0.57212 
1.72 628.49 0.0032953 0.57208 
1.82 628.48 0.0032953 0.5721 
1.93 628.5 0.0032953 0.57208 



















Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 264.57 0.0060455 0.5655 
1.11 265.07 0.0060455 0.58544 
1.21 265.19 0.0060455 0.67966 
1.31 265.25 0.0060455 0.74452 
1.41 265.01 0.0060455 0.78982 
1.51 264.79 0.0060455 0.8299 
1.61 264.8 0.0060455 0.87022 
1.72 264.69 0.0060455 0.91052 
1.82 265.13 0.0060455 0.95019 
1.93 265.3 0.0060455 0.9763 
2.03 265.35 0.0060455 0.98019 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 274.64 0.0061199 0.56488 
1.11 274.55 0.0061199 0.57641 
1.21 274.67 0.0061199 0.65331 
1.31 274.53 0.0061199 0.72525 
1.41 274.21 0.0061199 0.77328 
1.51 274.68 0.0061199 0.81273 
1.61 274.78 0.0061199 0.85075 
1.72 274.71 0.0061199 0.89214 
1.82 274.6 0.0061199 0.9237 
1.93 274.52 0.0061199 0.94747 









Magnesium – AZ80  
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 352.31 0.0078393 0.56236 
1.11 352.3 0.0078393 0.56252 
1.21 352.3 0.0078393 0.56301 
1.31 352.22 0.0078393 0.56486 
1.41 352.13 0.0078393 0.57916 
1.51 352.13 0.0078393 0.6455 
1.61 352.39 0.0078393 0.70741 
1.72 352.86 0.0078393 0.7541 
1.82 352.55 0.0078393 0.78777 
1.93 352.36 0.0078393 0.81959 
2.03 352.33 0.0078393 0.84701 
 
Table D.6. 





Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 302.61 0.0066985 0.56422 
1.11 302.58 0.0066985 0.56489 
1.21 302.53 0.0066985 0.56832 
1.31 302.47 0.0066985 0.59468 
1.41 302.72 0.0066985 0.67933 
1.51 302.96 0.0066985 0.73636 
1.61 303.13 0.0066985 0.77818 
1.72 302.54 0.0066985 0.81788 
1.82 302.64 0.0066985 0.85511 
1.93 302.57 0.0066985 0.8959 










Stainless Steel - 316 L 
 
Table D.8. 





Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 653 0.0033886 0.62675 
1.11 653 0.0033886 0.62676 
1.21 653 0.0033886 0.62673 
1.31 653 0.0033886 0.62677 
1.41 653 0.0033886 0.62676 
1.51 653 0.0033886 0.62681 
1.61 653 0.0033886 0.62682 
1.72 653 0.0033886 0.62684 
1.82 653 0.0033886 0.62685 
1.93 653 0.0033886 0.62683 
2.03 653 0.0033886 0.62683 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 1148 0.0047325 0.48944 
1.11 1148 0.0047325 0.62601 
1.21 1148 0.0047325 0.62603 
1.31 1148 0.0047325 0.62602 
1.41 1148 0.0047325 0.62604 
1.51 1148 0.0047325 0.62605 
1.61 1148 0.0047325 0.62606 
1.72 1148 0.0047325 0.62618 
1.82 1148 0.0047325 0.62619 
1.93 1148 0.0047325 0.6262 


















Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 265.97 0.0060455 0.62414 
1.11 265.97 0.0060455 0.62417 
1.21 265.97 0.0060455 0.6242 
1.31 265.97 0.0060455 0.62421 
1.41 265.97 0.0060455 0.62423 
1.51 265.97 0.0060455 0.62424 
1.61 265.97 0.0060455 0.62421 
1.72 265.97 0.0060455 0.6242 
1.82 265.97 0.0060455 0.62418 
1.93 265.97 0.0060455 0.62415 
2.03 265.97 0.0060455 0.62411 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 275.97 0.0061199 0.62408 
1.11 275.97 0.0061199 0.62411 
1.21 275.97 0.0061199 0.62413 
1.31 275.97 0.0061199 0.62416 
1.41 275.97 0.0061199 0.62414 
1.51 275.97 0.0061199 0.62415 
1.61 275.97 0.0061199 0.62415 
1.72 275.97 0.0061199 0.62415 
1.82 275.97 0.0061199 0.62414 
1.93 275.97 0.0061199 0.62412 









Magnesium – AZ80  
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 353.97 0.0078393 0.62369 
1.11 353.97 0.0078393 0.62371 
1.21 353.97 0.0078393 0.62374 
1.31 353.97 0.0078393 0.62376 
1.41 353.97 0.0078393 0.62378 
1.51 353.97 0.0078393 0.6238 
1.61 353.97 0.0078393 0.62382 
1.72 353.97 0.0078393 0.62382 
1.82 353.97 0.0078393 0.62383 
1.93 353.97 0.0078393 0.62383 
2.03 353.97 0.0078393 0.62386 
 
Table D.12. 
Magnesium – ZK60 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 303.97 0.006698 0.62417 
1.11 303.97 0.006698 0.62419 
1.21 303.97 0.006698 0.62422 
1.31 303.97 0.006698 0.62424 
1.41 303.97 0.006698 0.62426 
1.51 303.97 0.006698 0.62427 
1.61 303.97 0.006698 0.62428 
1.72 303.97 0.006698 0.62429 
1.82 303.97 0.006698 0.62429 
1.93 303.97 0.006698 0.62428 















Stainless Steel  – 316L 
 
Table D.14. 
Cobalt- Chromium – L 605 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 1120.3 0.0047199 0.5955 
1.11 1120.3 0.0047199 0.59566 
1.21 1120.3 0.0047199 0.59581 
1.31 1120.3 0.0047199 0.59597 
1.41 1120.3 0.0047199 0.59614 
1.51 1120.3 0.0047199 0.5963 
1.61 1120.4 0.0047199 0.59647 
1.72 1120.4 0.0047199 0.59666 
1.82 1120.4 0.0047199 0.59684 
1.93 1120.4 0.0047199 0.59704 





Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 645.77 0.0033886 0.60147 
1.11 645.78 0.0033886 0.60178 
1.21 645.78 0.0033886 0.60211 
1.31 645.78 0.0033886 0.60244 
1.41 645.79 0.0033886 0.60275 
1.51 645.8 0.0033886 0.60314 
1.61 645.8 0.0033886 0.60352 
1.72 645.81 0.0033886 0.60396 
1.82 645.82 0.0033886 0.60436 
1.93 645.82 0.0033886 0.60485 









Magnesium  – WE43 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 266 0.0060455 0.59732 
1.11 266 0.0060455 0.59837 
1.21 266 0.0060455 0.59959 
1.31 266 0.0060455 0.60101 
1.41 266 0.0060455 0.60272 
1.51 266 0.0060455 0.60483 
1.61 266 0.0060455 0.60451 
1.72 266 0.0060455 0.61144 
1.82 266 0.0060455 0.6164 
1.93 265.99 0.0060455 0.62449 
2.03 265.99 0.0060455 0.6356 
 
Table D.16. 





Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 276 0.0061199 0.59724 
1.11 276 0.0061199 0.59825 
1.21 276 0.0061199 0.59935 
1.31 276 0.0061199 0.60066 
1.41 276 0.0061199 0.60222 
1.51 276 0.0061199 0.60413 
1.61 276 0.0061199 0.60653 
1.72 275.99 0.0061199 0.61001 
1.82 275.99 0.0061199 0.61432 
1.93 275.99 0.0061199 0.62119 









Magnesium – AZ80 
Pressure (Mpa) Stress (Mpa) Strain (mm/mm) Total Deformation (mm) 
1.01 354 0.0078393 0.60655 
1.11 354 0.0078393 0.60726 
1.21 354 0.0078393 0.608 
1.31 354 0.0078393 0.6088 
1.41 354 0.0078393 0.60966 
1.51 354 0.0078393 0.61062 
1.61 354 0.0078393 0.61168 
1.72 354 0.0078393 0.613 
1.82 354 0.0078393 0.61438 
1.93 354 0.0078393 0.61614 
2.03 354 0.0078393 0.61805 
 
Table D.18. 






Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 303.98 0.0068042 0.60772 
1.11 303.98 0.0067954 0.60947 
1.21 303.98 0.0067998 0.60856 
1.31 303.98 0.0067914 0.61047 
1.41 303.98 0.0067876 0.61159 
1.51 305.44 0.0067858 0.61283 
1.61 307.1 0.0068213 0.61426 
1.72 308.93 0.0068604 0.61608 
1.82 310.61 0.0068961 0.61806 
1.93 312.43 0.006935 0.62073 










Stainless Steel  – 316L 
 
Table D.20. 




Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 481.46 0.0026264 0.55251 
1.11 486.42 0.0026476 0.57726 
1.21 503.8 0.0027206 0.63331 
1.31 517.36 0.0027817 0.67317 
1.41 527.02 0.002826 0.7026 
1.51 534.25 0.0028591 0.72564 
1.61 539.93 0.0028846 0.74491 
1.72 545.12 0.002908 0.76381 
1.82 549.25 0.002926 0.77906 
1.93 552.37 0.002939 0.7942 
2.03 554.88 0.0029484 0.80647 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 829.19 0.0035944 0.54098 
1.11 828.59 0.0035918 0.54131 
1.21 828.41 0.0035912 0.54176 
1.31 828.41 0.0035914 0.54231 
1.41 828.5 0.003592 0.54312 
1.51 828.33 0.0035913 0.54408 
1.61 828.34 0.0035913 0.54559 
1.72 828.62 0.0035919 0.54839 
1.82 828.38 0.0035933 0.55285 
1.93 828.21 0.0036048 0.56652 









Magnesium – WE43 
Pressure (MPa) Stress (MPa) Strain (mm/mm) Total Deformation (mm) 
1.01 261.31 0.0060455 0.76132 
1.11 261.33 0.0060455 0.54551 
1.21 261.36 0.0060455 0.54662 
1.31 261.41 0.0060455 0.54791 
1.41 261.44 0.0060455 0.54936 
1.51 261.42 0.0060455 0.55589 
1.61 263.25 0.0060455 0.59938 
1.72 265.19 0.0060455 0.65046 
1.82 265.35 0.0060455 0.6913 
1.93 265.39 0.0060455 0.71857 
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